3-((diallylamino)methyl)-2-methylquinolin-4-ol

ID: ALA4856427

PubChem CID: 720679

Max Phase: Preclinical

Molecular Formula: C17H20N2O

Molecular Weight: 268.36

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCN(CC=C)Cc1c(C)nc2ccccc2c1O

Standard InChI:  InChI=1S/C17H20N2O/c1-4-10-19(11-5-2)12-15-13(3)18-16-9-7-6-8-14(16)17(15)20/h4-9H,1-2,10-12H2,3H3,(H,18,20)

Standard InChI Key:  PKMKEMIYJSQJSE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   24.6135   -3.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9005   -3.9158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8967   -4.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6020   -5.1495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3182   -3.9268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3093   -4.7446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0119   -5.1593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7238   -4.7575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7288   -3.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0256   -3.5256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1872   -5.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1955   -3.5026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2008   -2.6855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4958   -2.2722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9112   -2.2815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6162   -2.6947    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.9165   -1.4643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6269   -1.0604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7854   -2.6762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0804   -2.2630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  2  0
  3 11  1  0
  1 16  1  0
  2 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 17  1  0
 17 18  2  0
 14 19  1  0
 19 20  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

EGLN1 Tclin Egl nine homolog 1 (1702 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.36Molecular Weight (Monoisotopic): 268.1576AlogP: 3.42#Rotatable Bonds: 6
Polar Surface Area: 36.36Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.62CX Basic pKa: 7.88CX LogP: 3.17CX LogD: 2.69
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.82Np Likeness Score: -0.94

References

1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L..  (2021)  Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2.,  38  [PMID:33862469] [10.1016/j.bmc.2021.116115]

Source